abs810008 SP600125
| 參考價 | ￥546.00-￥772.00 |
具體成交價以合同協(xié)議為準
- 公司名稱 愛必信（上海）生物科技有限公司
- 品牌absin
- 型號abs810008
- 所在地上海市
- 廠商性質生產廠家
- 更新時間2024/10/21 15:47:24
- 訪問次數 922
規(guī)格
| 10mg | 546.00元 | 999 件可售 |
| 50mg | 772.00元 | 999 件可售 |
聯(lián)系方式：愛必信021-38015121 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網上看到的信息，謝謝!
| CAS | 129-56-6 | 純度 | >98 % |
|---|---|---|---|
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10mg;50mg |
| 貨號 | abs810008 | 應用領域 | 生物產業(yè),綜合 |
| 主要用途 | - |
| 產品描述 | |
| 描述 | SP600125是一種廣譜JNK抑制劑，作用于JNK1，JNK2和JNK3，無細胞試驗中IC50分別為40nM，40nM和90nM，比作用于MKK4選擇性高10倍，比作用于MKK3，MKK6，PKB，和PKCα選擇性高25倍，比作用于ERK2，p38，Chk1，EGFR等選擇性高100倍。 |
| 純度 | >98 % |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | SP 600125；SP-600125；Nsc75890 |
| 外觀 | Lyophilized powder |
| 可溶性/溶解性 | DMSO: ≥ 44 mg/mL |
| 生物活性 | |
| 靶點 | JNK1；JNK2；Aurora A；TrkA ；JNK3 |
| In vitro(體外研究) | SP600125 is originally characterized as a selective ATP-competitive inhibitor of c-Jun N-terminal kinase JNK. In Jurkat T cells, SP600125 inhibits the phosphorylation of c-Jun with IC50 of 5 μM to 10 μM. In CD4+ cells, such as Th0 cells isolated from either human cord or peripheral blood, SP600125 blocks cell activation and differentiation and inhibits the expression of inflammatory genes COX-2, IL-2, IL-10, IFN-γ, and TNF-α, with IC50 of 5 μM to 12 μM. However, later studies reveal that SP600125 also suppresses aryl hydrocarbon receptor (AhR) , Mps1 , and a panel of other serine/threonine kinases, including Aurora kinase A, FLT3, MELK, and TRKA .In a mouse beta cells MIN6, SP600125 (20 μM) induces the phosphorylation of p38 MAPK and its downstream CREB-dependent promoter activation. In HCT116 cells, SP600125 (20 μM) blocks the G2 phase to mitosis transition and induces endoreplication. This ability of SP600125 is independent of JNK inhibition, but due to its inhibition of CDK1-cyclin B activation upstream of Aurora A and Polo-like kinase 1. |
| In vivo(體內研究) | In mice, SP600125 (15 mg/kg or 30 mg/kg) significantly inhibits lipopolysaccharide (LPS)-induced TNF-α expression and anti-CD3-induced apoptosis of CD4+ CD8+ thymocytes. |
| 參考文獻 | |
| 參考文獻 | [1] Bennett BL, et al. Proc Natl Acad Sci U S A, 2001, 98(24), 13681-13686. [2] Joiakim A, et al. Drug Metab Dispos, 2003, 31(11), 1279-1282. [3] Schmidt M, et al. EMBO Rep, 2005, 6(9), 866-872. |
溫馨提示：本產品僅作科研實驗使用，不支持臨床等研究
采購中心
化工儀器網